MSC Transplantation Attenuates Inflammation, Prevents Endothelial Damage and Enhances the Angiogenic Potency of Endogenous MSCs in a Model of Pulmonary Arterial Hypertension
Authors:
Open Access
- 1 March 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 2087-2101
Abstract
Purpose: Pulmonary arterial hypertension (PAH) is a progressive and fatal pulmonary vascular disease initiated by endothelial dysfunction. Mesenchymal stromal cells (MSCs) have been shown to ameliorate PAH in various rodent models; however, these models do not recapitulate all the histopathological alterations observed in human PAH. Broiler chickens (Gallus gallus) can develop PAH spontaneously with neointimal and plexogenic arteriopathy strikingly similar to that in human patients. Herein, we examined the protective effects of MSC transplantation on the development of PAH in this avian model. Methods: Mixed-sex broilers at 15 d of age were received 2× 106 MSCs or PBS intravenously. One day later, birds were exposed to cool temperature with excessive salt in their drinking water to induce PAH. Cumulative morbidity from PAH and right-to-left ventricle ratio were recorded. Lung histologic features were evaluated for the presence of endothelial damage, endothelial proliferation and plexiform lesions. Expression of proinflammatory mediators and angiogenic factors in the lung was detected. Matrigel tube formation assay was performed to determine the angiogenic potential of endogenous MSCs. Results: MSC administration reduced cumulative PAH morbidity and attenuated endothelial damage, plexiform lesions and production of inflammatory mediators in the lungs. No significant difference in the expression of paracrine angiogenic factors including VEGF-A and TGF-β was determined between groups, suggesting that they are not essential for the beneficial effect of MSC transplantation. Interestingly, the endogenous MSCs from birds receiving MSC transplantation demonstrated endothelial differentiatial capacity in vitro whereas those from the mock birds did not. Conclusion: Our results support the therapeutic use of MSC transplantation for PAH treatment and suggest that exogenous MSCs produce beneficial effects through modulating inflammation and endogenous MSC-mediated vascular repair. Graphical Abstract:Keywords
This publication has 60 references indexed in Scilit:
- Spindle Shaped Human Mesenchymal Stem/Stromal Cells from Amniotic Fluid Promote NeovascularizationPLOS ONE, 2013
- Plexiform Lesions in Pulmonary Arterial HypertensionThe American Journal of Pathology, 2011
- Mechanisms of disease: pulmonary arterial hypertensionNature Reviews Cardiology, 2011
- Idiopathic pulmonary arterial hypertension: An avian model for plexogenic arteriopathy and serotonergic vasoconstrictionJournal of Pharmacological and Toxicological Methods, 2011
- Isolation and Differentiation of Chicken Mesenchymal Stem Cells From Bone MarrowStem Cells and Development, 2009
- Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturingJournal of Anatomy, 2009
- The effect of dietary l‐carnitine supplementation on pulmonary hypertension syndrome mortality in broilers exposed to low temperaturesJournal of Animal Physiology and Animal Nutrition, 2007
- The injury effect of oxygen free radicals in vitro on cultured pulmonary artery endothelial cells from broilersResearch in Veterinary Science, 2007
- l-Arginine inhibiting pulmonary vascular remodelling is associated with promotion of apoptosis in pulmonary arterioles smooth muscle cells in broilersResearch in Veterinary Science, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003